![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Awards Orphan Drug Designation to TapImmune Cancer Vaccine
FDA Awards Orphan Drug Designation to TapImmune Cancer Vaccine
![](https://www.fdanews.com/ext/resources/test/Drug-Images4/TapImmnue_Logo.gif?t=1453315501&width=430)
TapImmune has scored FDA orphan drug designation for its cancer vaccine TPIV 200 for ovarian cancer.
The multi-epitope peptide vaccine targets folate receptor alpha, a protein overexpressed in multiple cancers, including more than 90 percent of ovarian cancer cells.
Upcoming Events
-
21Oct